FII Holdings

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1522.555.4 (+0.36 %)
PREV CLOSE ( ) 1517.15
OPEN PRICE ( ) 1505.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 145686
TODAY'S LOW / HIGH ( )1502.15 1528.90
52 WK LOW / HIGH ( )922.55 1638.7
NSE1522.806.4 (+0.42 %)
PREV CLOSE( ) 1516.40
OPEN PRICE ( ) 1505.00
BID PRICE (QTY) 1522.80 (296)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2536516
TODAY'S LOW / HIGH( ) 1503.70 1528.30
52 WK LOW / HIGH ( )922.45 1638.85
upfii downfii 
Current Quarter
Prev Quarter
Company Quarter Ended 202403 % of Share Quarter Ended 202312 % of Share Changeupfii

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.